Drug Discovery Advisory Group Members

Name Organisation Position
Andy Takle (Chair of the group) Cancer Research UK Director of Clinical and Translational Research
Hilary Calvert Newcastle University Chair of the Cancer Research UK New Agents Committee (NAC)
Bob Jackson Independent consultant Chair of the Cancer Research UK Discovery Committee (DC)
Simon Campbell Independent consultant Former senior vice-president for worldwide discovery and medicinal research at Pfizer
Herman Waldmann University of Oxford Head of the Sir William Dunn School of Pathology
Peter Machin Independent consultant Previously senior vice-president in discovery research and vice-president of chemistry and screening at GlaxoSmithKline; previously head of chemistry at Roche
Fiona Marshall Independent consultant Chief scientific officer of Heptares Therapeutics Ltd (a MRC Laboratory of Molecular Biology spin-off drug discovery company)
John Tite Independent consultant Chief executive office of Bicycle Therapeutics in Cambridge, UK
Chris Swain Independent consultant Founder of Cambridge MedChem Consulting; previously at Merck UK.